Although several Ca2+ channels, transporters, and Ca2+-binding proteins are compromised in PD, the significant impact of NCX modulation in PD pathology suggests that regulating its activity may provide a promising avenue for in vivo experiments aimed at developing new therapeutic strategies. The gene discussed is TLX2; the disease is Parkinson disease.